European Oncology & Haematology Foreword Axel Heidenreich Special Report The European Cancer Congress 2013 – The Largest Platform for Practice-changing Data in Europe Catherine Shiels Ovarian Cancer NGR-hTNF plus Doxorubicin in Relapsed Ovarian Carcinoma Domenica Lorusso, Maria Mancini, Italo Sarno, Antonio Lambiase, Francesco Raspagliesi Temporary Ovarian Suppression in the Prevention of Chemotherapy-induced Premature Menopause in Early-stage Breast Cancer Patients Martina Nunzi, Silvia Sabatini Squamous Cell Carcinoma Arising in a Mature Cystic Teratoma of the Ovary: A Case Series and Review of the Literature James R Powell, Krishnayan Haldar Breast Cancer Current Status and New Developments in Breast Cancer Diagnosis and Detection Dimitrios Tzias D, Elizabeth AM O'Flynn, Steven D Allen, Robin M Wilson Prostate Cancer Castration-resistant Prostate Cancer – Chemotherapies and Molecular Targets Amit Bahl Modern Management of Castration-resistant Prostate Cancer Axel Heidenreich, David Pfister, Axel Merseburger, Georg Bartsch Sarcomas Radiotherapy Controversies in the Radical Treatment of Soft-tissue Sarcomas of the Limb Claire P Esler, Robert U Ashford Supportive Oncology Prevention of Cachexia in Cancer Ross W Stewart, Neil Johns, Kenneth C Fearon A Review of the Prevention of Nausea and Vomiting Induced by Chemotherapy Rudolph M Navari Cancer Control Target therapies-induced Cardiotoxicity Ludovico Lazzari, Marcella De Paolis, Daniella Bovelli, Enrico Boschetti Foreword Cynthia N Rittenberg Practice Management Streamlining Workflows Across Multiple Cancer Centres with the MOSAIQ® Oncology Information System Laura Francis Original Contributions Ability of the Comprehensive Geriatric Assessment to Predict Frailty in Older People Diagnosed with Cancer in a General Hospital Maria José Molina-Garrido, Carmen Guillén-Ponce HIV-associated Thrombotic Thrombocytopenic Purpura – What We Know So Far Muriel Meiring, Mike Webb, Dominique Goedhals, Vernon Louw Initial Experience with Determination of hTERC and MYCC Amplification in Cervical Intraepithelial Neoplasia and Cervical Carcinoma in the Czech Republic Lucie Moukova, Vladimira Vranova, Iva Slamova, Miroslava Kissova, Petr Kuglik Supportive Oncology Meeting Educational Needs and Enhancing Adherence of Patients Receiving Oral Cancer Agents Through Use of the MASCC Oral Agent Teaching Tool© Cynthia N Rittenberg Head & Neck Cancer Bevacizumab Therapy for Choroidal Melanoma Breno R Lima, Arun D Singh Gastrointestinal Cancer Current Standards and New Trends in Oesophageal Cancer Florian Lordick Gynaecological Cancer NGR-hTNF plus Doxorubicin in Recurrent Ovarian Cancer Domenica Lorusso, Paola Malaguti, Giovanni Scambia, Claudio Bordignon, Francesco Raspagliesi Special Focus – Haematological Malignancies Elacytarabine – A New Agent in the Treatment of Relapsed/Refractory Acute Myeloid Leukaemia Norbert Vey Treatment of Relapsed or Refractory Multiple Myeloma in the Era of Novel Agents Federica Cavallo, Barbara Lupo, Antonio Palumbo Management Strategies for Elderly Patients with Diffuse Large B-Cell Lymphoma Loretta J Nastoupil, Rajni Sinha, Christopher R Flowers Transfusion Serious Hazards of Transfusion Haemovigilance – The UK Experience Paula HB Bolton-Maggs, Hannah Cohen, Serious Hazards of Transfusion Steering Group Paediatric Oncology Very Rare Tumours in Paediatric Age – From ‘Tumori Rari in Età Pediatrica’ to the European Cooperative Study Group for Paediatric Rare Tumours Gianni Bisogno, Giovanni Cecchetto, Andrea Ferrari